Entera Bio Ltd Financial Flexibility Index
Entera Bio Ltd financial flexibility index. Entera Bio Ltd (ENTX) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of $-3.46 Million (operating CF $-3.46 Million minus capex $3.00K) represents 0% of total liabilities ($12.21 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Entera Bio Ltd (2015–2025)
Financial flexibility index of Entera Bio Ltd from 2015 to 2025. Historical Financial Flexibility Index trend for Entera Bio Ltd across 11 annual periods. Check Entera Bio Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Entera Bio Ltd Financial Flexibility Index by Year (2015–2025)
Entera Bio Ltd financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for Entera Bio Ltd. For the full cash flow conversion analysis, see Entera Bio Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.51x | $-7.26 Million | $-7.37 Million | $2.89 Million | ▲ +51.7% |
| 2024 | -5.20x | $-6.82 Million | $-6.82 Million | $1.31 Million | ▲ +1.6% |
| 2023 | -5.29x | $-7.29 Million | $-7.31 Million | $1.38 Million | ▲ +41.7% |
| 2022 | -9.07x | $-12.45 Million | $-12.50 Million | $1.37 Million | ▼ -243.1% |
| 2021 | -2.64x | $-9.05 Million | $-9.06 Million | $3.42 Million | ▲ +44.3% |
| 2020 | -4.75x | $-10.50 Million | $-10.56 Million | $2.21 Million | ▼ -155.9% |
| 2019 | -1.86x | $-8.88 Million | $-8.92 Million | $4.78 Million | ▲ +38.5% |
| 2018 | -3.02x | $-9.73 Million | $-9.80 Million | $3.23 Million | ▼ -2922.2% |
| 2017 | -0.10x | $-4.47 Million | $-4.53 Million | $44.84 Million | ▼ -1.5% |
| 2016 | -0.10x | $-3.10 Million | $-3.14 Million | $31.53 Million | ▲ +18.7% |
| 2015 | -0.12x | $-3.44 Million | $-3.50 Million | $28.43 Million | — |